Short communicationPublished 21 Oct 2021

Basophil Activation Test as the Biomarker of Allergic Desensitization

Authors: Gennaro Maietta

Reproductive Immunology: Open Access

Volume 5 · Issue 5 · Pages 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Specific immunotherapy (SIT) is able to modify the natural history of allergic diseases (1). In particular, SIT induces an immunological tolerance against the allergen and clinical control of disease. Clinical efficacy of subcutaneously SIT (SCIT) has been clearly demonstrated (2) as well as sublingual SIT (SLIT) (3), but we need to identify biological markers for SIT in the attempt to reveal patients with high risk of adverse reactions, to monitor the therapy outcome and to predict relapses after SIT discontinuation. We know that both SCIT and SLIT induce a sudden increase of the basophil sensitivity in the first weeks of immunotherapy followed by a gradual decrease over some months (4). The purpose of this study is to evaluate if Basophil Activation Test (BAT) can monitor the progressive desensitization of the patient during SIT.

Keywords

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.

Try:

More from this journal

The newest in Reproductive Immunology: Open Access.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalReproductive Immunology: Open Access
  • SubjectImmunology & Microbiology
  • SubjectReproductive Medicine & Gynaecology
  • BylineArticles whose byline prints “Gennaro Maietta”